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Abstract
The membrane-anchored proteins of enveloped viruses form labile spikes on the virion surface, primed to undergo large-
scale conformational changes culminating in virus-cell membrane fusion and viral entry. The prefusion form of these
envelope glycoproteins thus represents an important molecular target for antiviral intervention. A critical roadblock to this
endeavor has been our inability to produce the prefusion envelope glycoprotein trimer for biochemical and structural
analysis. Through our studies of the GPC envelope glycoprotein of the hemorrhagic fever arenaviruses, we have shown that
GPC is unique among class I viral fusion proteins in that the mature complex retains a stable signal peptide (SSP) in addition
to the conventional receptor-binding and transmembrane fusion subunits. In this report we show that the recombinant GPC
precursor can be produced as a discrete native-like trimer and that its proteolytic cleavage generates the mature
glycoprotein. Proteoliposomes containing the cleaved GPC mediate pH-dependent membrane fusion, a characteristic
feature of arenavirus entry. This reaction is inhibited by arenavirus-specific monoclonal antibodies and small-molecule
fusion inhibitors. The in vitro reconstitution of GPC-mediated membrane-fusion activity offers unprecedented opportunities
for biochemical and structural studies of arenavirus entry and its inhibition. To our knowledge, this report is the first to
demonstrate functional reconstitution of membrane fusion by a viral envelope glycoprotein.
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Introduction
Entry of enveloped viruses into their host cells requires fusion of
the viral and cellular membranes, a process that is mediated by the
viral envelope glycoprotein. Class I viral fusion proteins, including
those of influenza and human immunodeficiency virus type 1
(HIV-1), are synthesized as inactive precursor glycoproteins that
assemble as trimers and are subsequently primed by proteolytic
cleavage to generate the mature fusogenic spikes. The membrane-
anchored spike is thought to exist in a kinetically trapped
metastable state that can be triggered, by engagement with cell-
surface receptor or exposure to acidic pH in the endosome, to
undergo a series of structural transitions leading to a thermody-
namically favored postfusion state and concomitant virus-cell
membrane fusion (reviewed in references [1,2]). Intervention
strategies that prevent membrane fusion and virus entry thus
provide a sound basis for vaccine and drug development. A
detailed mechanistic understanding of viral membrane fusion and
its inhibition has been hindered by the inherent instability of the
prefusion envelope glycoprotein trimer. Solubilization from its
membrane-anchored environment invariably causes disassembly
and/or refolding to the postfusion conformation. X-ray crystallo-
graphic analyses of the most extensively characterized class I
envelope glycoproteins – influenza virus hemagglutinin (HA),
HIV-1 envelope glycoprotein (Env) and parainfluenza virus 5 F
(PIV5 F) - are based on soluble ectodomain fragments. These
studies necessarily exclude information regarding the important
role of membrane anchorage in envelope glycoprotein assembly,
maintenance of the prefusion state and activation of fusogenic
conformational changes. The failure of current HIV-1 vaccines to
elicit broadly neutralizing antibodies is largely attributed to our
inability to produce the trimeric native Env immunogen in
a prefusion conformation [3].
Arenaviruses are responsible for severe hemorrhagic fevers
worldwide, and Junı́n (JUNV) and Lassa (LASV) viruses are
recognized to pose significant threats to public health and
biodefense [4–8]. Arenavirus entry into the host cell is mediated
by the viral envelope glycoprotein GPC, a member of the class I
viral fusion proteins. The GPC precursor trimerizes and is
proteolytically cleaved by the cellular site-1-protease/subtilisin-
like kexin isozyme-1 (S1P/SKI-1) [9–11] in the Golgi to generate
the receptor-binding (G1) and transmembrane fusion (G2)
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subunits. Upon engaging a cell-surface receptor – transferrin
receptor 1 (TfR1) for JUNV [12] or alpha-dystroglycan for LASV
[13] - the virion is endocytosed and GPC-mediated fusion is
triggered by acidic pH in the maturing endosome [14]. The
ensuing conformational changes are driven by formation of the
stable postfusion trimer-of-hairpins in G2 [15–17]. Unlike other
class I fusion proteins, the mature GPC retains its signal peptide as
an essential subunit [18,19]. The unusually long (58 amino-acid
residues) stable signal peptide (SSP) traverses the membrane twice
[20] and binds the cytoplasmic domain of G2 via an intersubunit
zinc finger [21,22]. Evidence suggests that SSP interacts with the
ectodomain of G2 to maintain the prefusion GPC complex at
neutral pH and facilitate its fusogenic response to acidic pH [23].
Importantly, small-molecule fusion inhibitors [24–26] target the
pH-sensitive SSP-G2 interface to prevent fusion of the viral and
endosomal membranes, and thereby viral entry [23].
Our previous studies showed that the JUNV GPC precursor
purified from insect cells exists as a stable trimer and efficiently
binds the TfR1 receptor and arenavirus-specific small-molecule
fusion inhibitors [27]. The unusual structural integrity of the
precursor likely reflects its unique tripartite organization, and
suggested the feasibility of generating the mature GPC complex
for biochemical analysis. To this end, we have produced the
prefusion GPC trimer through in vitro proteolytic cleavage, and
demonstrated that proteoliposomes containing this complex are
able to mediate pH-dependent membrane fusion that is specifically
inhibited by small-molecule fusion inhibitors. Biochemical re-
constitution of the fusogenic activity of GPC provides a platform
for understanding pH-induced membrane fusion and its in-
hibition.
Materials and Methods
Monoclonal Antibodies (MAbs) and Small-molecule
Fusion Inhibitors
MAbs directed to JUNV G1 (BF11, BF09, BE08 and AG02)
and N (BG12) were obtained from the CDC [28] through the
NIAID Biodefense and Emerging Infectious Diseases Research
Resources Repository. MAb F100G5 recognizes the fusion peptide
of JUNV G2 [16] and was provided by the Public Health Agency
of Canada. Plasma-derived human soluble TfR (sTfR) was
obtained from American Research Products, and the M2 anti-
FLAG MAb from Sigma.
The small-molecule fusion inhibitors discovered by SIGA
Technologies - ST-193 [25], ST-161 [26], ST-761 [27], ST-294
[24] and its dansyl analog ST-375 [27] -were obtained from the
company. Compounds discovered at The Scripps Research
Institute (TSRI) - 17C8 and 8C1 [29] - were provided by Stefan
Kunz, Andrew M. Lee and Michael B. A. Oldstone. ST-294 and
ST-761 are specific to New World (NW) arenaviruses and ST-161
and TSRI 8C1 are specific to the Old World (OW) LASV. ST-193
and TSRI 17C8 are broadly active against NW and OW viruses.
Expression and Purification of rGPCfur
Recombinant baculoviruses were constructed as previously
described [27] using a pFastBac Dual expression vector (Life
Technologies) and separate SSP and G1G2 precursor open-
reading frames from GPC of the pathogenic MC2 strain of JUNV
[19]. These two polypeptides associate in trans to reconstitute the
native GPC complex [18,19,27]. The signal peptide of human
CD4 was fused to the N-terminus of the G1G2 precursor, to which
a C-terminal extension bearing a TEV-protease site and FLAG-
tag sequence was added [27]. The furin recognition motif was
introduced using QuikChange mutagenesis (Stratagene). Baculo-
virus expressing rGPCfur was used to infect Trichoplusia ni High-
FiveTM cells and washed cell membranes were solubilized in 1.5%
dodecyl beta-D-maltoside (DDM) as previously described [27].
rGPCfur was bound to immobilized M2 anti-FLAG MAb beads
(Sigma), and eluted in buffer containing 0.1% DDM and 5 mM
3xFLAG peptide (Sigma). This material was dialyzed to remove
the 3xFLAG peptide and subjected to size-exclusion chromatog-
raphy using a Superdex-200/G-75 tandem column (GE Health-
care) in buffer containing 0.05% DDM. All buffers contained
100 mM Zn++ to prevent dissociation from the intersubunit zinc-
binding domain of GPC. Proteins were analyzed by sodium
dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
using NuPAGE 4–12% bis-Tris gels (Life Technologies). For mass
spectrometry, proteins were eluted from gels in 0.15 M NaOH
and subsequently neutralized and deglycosylated using PNGase F
(New England Biolabs). Molecular weights were determined using
a MALDI (Voyager DE) mass spectrometer.
Soluble Human Furin (sFurin)
A plasmid for baculovirus expression of the recombinant soluble
prodomain of human furin [30] was kindly provided by Dr. Alex
Strongin (Burnham Institute for Medical Research) and the open-
reading frame, including the baculovirus gp67 signal peptide and
C-terminal hexa-histidine tag, was transferred to pFastBac1 (Life
Technologies) for generating baculovirus. The soluble furin
enzyme was purified from the supernatant of infected Spodoptera
frugiperda (Sf9) cells using Ni++-affinity chromatography as de-
scribed [30]. The purified sFurin (,33,000 units/mg [31])
contained no detectable nonspecific protease activity. Cleavage
of rGPCfur in solution (0.6 mg/ml) was performed using a 3:1
molar ratio of rGPCfur:sFurin at 20uC for 4 hr in buffer containing
50 mM Tris (pH 7.2), 150 mM NaCl, 5 mM MgCl2, 1 mM
CaCl2, 100 mM ZnSO4 and 0.05% DDM. Zn++ was present to
stabilize the intersubunit zinc-binding domain in GPC and did not
appear to reduce the extent of furin cleavage [32]. In preliminary
studies, soluble human furin was purchased from New England
Biolabs.
Surface Plasmon Resonance (SPR) Studies
SPR analyses of binding to rGPCCD and rGPCfur were
performed using a Biacore T100 instrument (GE Healthcare) as
previously described [27]. The proteins are immobilized to the
biosensor chip via covalently coupled M2 anti-FLAG MAb. In
most experiments, rGPCfur was reconstituted into a lipid bilayer
on the chip as previously described [27]. Briefly, a Biacore L1
chip bearing immobilized rGPCfur in DDM-containing running
buffer was rinsed with 20 mM 3-[(3 cholamidopropyl) dimethy-
lammonio]-1-propanesulfonate (CHAPS) (Sigma) and the de-
tergent-containing buffer was replaced by liposomes containing
a 3:1 mixture of dimyristoylphosphatidylcholine and phospha-
tidylcholine (DMPC:PC; Avanti Polar Lipids) in running buffer
without DDM (non-detergent running buffer). By this pro-
cedure, protein-bound detergent is displaced by a lipid bilayer
that forms on the hydrophobic chip [33]. At the completion of
the SPR experiment, the L1 chip was regenerated with
isopropanol/40 mM NaOH (2:3 v/v) to remove lipids and
associated proteins, and the M2 MAb was reconditioned using
glycine:HCl, pH 3.0.
For proteolytic cleavage of rGPCfur, the L1 chip was incubated
with 20,000 units/ml sFurin for 1 hr at 25uC in non-detergent
running buffer (containing 1 mM Zn++). The bolus of sFurin was
then washed off to achieve a stable baseline. In all binding studies,
multiple concentrations of MAb (0.1–2.5 mM), sTfR (0.5–5.0 mM)
and small-molecule fusion inhibitors (5–250 mM) were used to
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calculate the interaction parameters listed in Tables 1 and 2,
respectively.
pH-induced shedding of the G1 subunit was determined by
subjecting the cleaved rGPCfur to a 1 min pulse of non-detergent
running buffer that had been adjusted to pH 5.0 using PIPES or
sodium acetate. A new baseline was subsequently determined to
assess the loss of protein from the chip. In studies using ST-294 to
inhibit G1 shedding, 10–20 mM of the compound was included at
all stages of the experiment. The addition of ST-294 did not affect
sFurin cleavage.
Preparation of Liposomes and Proteoliposomes
DMPC:PC liposomes used to form lipid bilayers in SPR
studies were prepared as previously described [27]. For
liposomal fusion assays, large unilamellar vesicles (LUVs) were
prepared using a 7:3 mixture of POPG (1-palmitoyl,2-oleoyl-sn-
glycero-3-phosphoglycerol) and POPC (1-palmitoyl,2-oleoyl-sn-
glycero-3-phosphocholine) (Avanti Polar Lipids). Dried lipids
were hydrated in 10 mM Tris (pH 7.2), 100 mM NaCl, 50 mM
ZnSO4 and multilamellar liposomes were formed by repeated
cycles of freeze/thaw. LUVs were produced by extrusion
through 100-nm pore size polycarbonate membranes (Avestin).
To generate target liposomes bearing a self-quenching concen-
tration of the fluorescent lipid rhodamine-PE (1,2-dioleoyl-sn-
glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfo-
nyl); Avanti Polar Lipids), the lipid mix was doped with 1% of
the compound. For studies of content mixing (below), liposomes
included 10% cholesterol hemisuccinate and contained either
50 mM Zn++ (proteoliposomes) or 1 mM of the soluble zinc-
sensitive fluorophore FluoZin-1 (Life Technologies) and no Zn++
(target liposomes). Free Zn++ or unincorporated FluoZin-1 was
removed by dialysis or separation on a small Sepharose CL4B
(Sigma) column.
Proteoliposomes bearing rGPCfur were prepared by mixing
rGPCfur (in buffer containing 50 mM Zn++ and 0.05% DDM) with
the appropriate LUVs at a protein:lipid molar ratio of ,1:25.
After 30 min of incubation at room temperature, the proteolipo-
somes were desalted by size-exclusion chromatography using
Sepharose CL4B, and extruded through a polycarbonate mem-
brane (100-nm pore). Protein incorporation was generally .95%.
Proteoliposomal rGPCfur (1.5–3.0 mM protein) was cleaved prior
to use in fusion assays by incubation with 0.5 mM sFurin at 20uC
for 45 min in buffer containing 10 mM Tris (pH 7.2), 100 mM
NaCl.
Liposome Fusion Assays
Lipid mixing: Target liposomes containing rhodamine-PE were
added to furin-treated proteoliposomes (,1.5–3.0 mM rGPCfur in
50 mM lipid) at a ratio of 1:10, and lipid mixing was assessed
intermittently by fluorescence (excitation 508 nm; emission
600 nm) using a Perkin Elmer LS55 spectrometer. pH was
adjusted to 5.0 by the addition of 1 M sodium acetate, and
complete dequenching of the fluorophore was determined upon
solubilization in 2% Triton X-100. JUNV-specific MAbs and
small-molecule fusion inhibitors were pre-incubated with proteo-
liposomes at a concentration of 5 and 15 mM, respectively.
Content mixing: Target liposomes containing 1 mM FluoZin-1
were added to Zn++-containing furin-treated proteoliposomes
(,1.5–3.0 mM protein in 50 mM lipid) at a 1:10 ratio, and
content mixing was assessed as described above (excitation
370 nm; emission 485 nm). The fluorescence signal for complete
mixing was determined by solubilizing the liposomes in buffer
adjusted to 50 mM Zn++.
Expression of GPC in Mammalian Cells
GPC was expressed in Vero cells, with SSP and the G1G2
precursor in trans, using pcDNA-based plasmids and T7 poly-
merase provided by the recombinant vaccinia virus rTF7-3 [34].
pH-induced cell-cell fusion activity was characterized as previously
described [19].
Results
Expression of Recombinant GPC
In previous studies, we produced and characterized the
recombinant cleavage-defective JUNV GPC precursor protein
[27]. rGPCCD (previously referred to as icd-GPC) was purified
from membranes of baculovirus-infected insect cells and found to
retain its trimeric structure. We showed that the rGPCCD trimer
binds the JUNV TfR1 receptor [12], JUNV-neutralizing MAbs
[28], and small-molecule arenavirus-specific fusion inhibitors [27].
Because the rGPCCD mutant is unable to mediate membrane
fusion [19], we expressed wild-type rGPC. As previously described
[27], our expression strategy takes advantage of the unusual ability
of SSP to associate in trans with the G1G2 precursor to reconstitute
the native tripartite complex [18,35]. Thus, SSP and the wild-type
G1G2 precursor were co-expressed using a pFastBac-Dual dual-
promoter baculovirus vector. The G1G2 open-reading frame
contains a conventional signal peptide and a FLAG tag is
appended at the C-terminus to facilitate purification from
solubilized insect-cell membranes.





a rGPCCD Kd (nM)
b
MAb BF11 4.26105 0.007 16.66 (1.2) 10.1
MAb BF09 1.86105 0.062 344.44 (14.5) 219
MAb BE08 1.26105 0.081 675 (20.3) 125
MAb AG02 0.696105 0.085 1,231 (93.2) 583
sTfR 0.296105 0.078 2,689 (120.5) 1,296
aKd values are the means derived by fitting two or three independent biosensor
datasets. The number in parenthesis is the difference between the highest and
lowest Kd values from individual datasets.
bKd values for rGPC
CD binding are taken from Thomas et al. [27].
doi:10.1371/journal.pone.0051114.t001




21) Kd (mM)a rGPCCD Kd (mM)b
ST-294 7.96103 0.015 1.89 (0.3) 1.08
17C8 1.86103 0.031 17.22 (2.3) 9.50
ST-375 2.16103 0.02 9.52 (0.8) 3.45
ST-193 1.26103 0.02 16.66 (1.8) 10.52
ST-761 1.86103 0.02 11.11 (0.9) 8.67
aKd values are the means derived by fitting two or three independent biosensor
datasets. The number in parenthesis is the difference between the highest and
lowest Kd values from individual datasets.
bKd values for rGPC
CD binding are taken from Thomas et al. [27].
doi:10.1371/journal.pone.0051114.t002
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Despite the existence of an insect S1P/SKI-1 orthologue [36],
the wild-type rGPC was refractory to cleavage in insect cells.
Serendipitously, several laboratories had previously reported
functional GPC mutants in which the S1P/SKI-1 cleavage site
(RRSLK|A) was replaced by that of furin [37,38], a cellular
protease used in the maturation of other viral envelope
glycoproteins. We therefore introduced a furin recognition site
(RRRKR|A) into the JUNV G1G2 precursor (GPCfur) and
confirmed that the mutant protein was fusogenic when expressed
in mammalian cells (Fig. 1). In insect cells, however, rGPCfur
remained refractory to cleavage (Fig. 2A), perhaps reflecting the
differing specificity of the insect enzyme [39]. Based on these
results, we purified the rGPCfur precursor to investigate its
susceptible to in vitro cleavage by human furin.
Purification of the rGPCfur Precursor
The rGPCfur precursor was solubilized from insect-cell
membranes using 1.5% DDM and purified by affinity chroma-
tography using the C-terminal FLAG tag [27]. SDS-PAGE
analysis of the purified protein confirmed SSP association in the
rGPCfur complex as well as the lack of proteolytic cleavage in
insect cells (Fig. 2A). Similarly to rGPCCD [27], the rGPCfur
precursor formed a relatively homogenous oligomer on size-
exclusion chromatography, with an apparent molecular size
consistent with a trimer (,220 kDa) (Fig. 2A). The yield of
purified rGPCfur by this procedure was ,1 mg per liter of High-
FiveTM cell culture.
The furin-site mutation in rGPCfur did not appear to affect
recognition of the trimer by virus-neutralizing MAbs or the TfR1
receptor in SPR studies. Briefly, rGPCfur was captured onto
a hydrophobic Biacore L1 sensor chip using immobilized FLAG
MAb, and subsequently reconstituted into a lipid membrane
[27,33]. Using a panel of four well-characterized virus-neutralizing
MAbs directed to JUNV G1 [28], we found that the rGPCfur
precursor was antigenically indistinguishable from rGPCCD and
bound to soluble TfR1 with comparable affinity [27] (Fig. 3A and
Table 1). Together, these results suggest that the purified rGPCfur
trimer retains important aspects of the native structure.
Small-molecule Arenavirus-specific Fusion Inhibitors
Six chemically distinct classes of small-molecule arenavirus-
specific entry inhibitors have been identified through independent
high-throughput screening exercises at SIGA Technologies (SIGA)
and the Scripps Research Institute (TSRI) [24–26,29]. These
classes differ in their specificities for NW arenaviruses (JUNV)
and/or OW viruses (LASV) (see Materials and Methods) yet
appear to share a common binding site on GPC [26,27]. The
compounds are thought to act through the SSP-G2 interface to
stabilize prefusion GPC against activation at endosomal pH,
thereby inhibiting membrane fusion [26,27].
SPR studies were performed to determine the ability of these
inhibitors to bind lipid-reconstituted rGPCfur. Compounds active
against NW viruses (ST-294, ST-761, ST-193, and TSRI 17C8)
bound to JUNV rGPCfur, whereas LASV-specific compounds (ST-
161 and TSRI 8C1) did not (Fig. 3B). Furthermore, the
dissociation constants (Kds) were similar to those determined for
rGPCCD (Table 2), approaching concentrations required for 50%
inhibition of cell-cell fusion (IC50) by the wild-type GPC in
mammalian cell culture [27]. Collectively, our binding studies
suggest that the furin-site mutation is well tolerated, and that the
rGPCfur precursor produced in insect cells adopts a native-like
conformation.
Proteolytic Cleavage of Purified rGPCfur
For proteolytic cleavage of rGPCfur, we expressed recombinant
soluble human furin (sFurin) in insect cells and purified the
enzyme by Ni++-affinity chromatography [30]. sFurin digestion of
the purified rGPCfur precursor in nonionic detergent at 20uC
resulted in only partial (,40%) cleavage (Fig. 2B). We were unable
to identify conditions to drive the digestion to completion and
speculate that the engineered furin recognition site may not be
optimally presented for cleavage [40]. Nonetheless, MALDI mass
spectrometric analysis of the G1 and G2 subunits generated by
furin digestion at 20uC confirmed cleavage at the predicted site
(RRRKR|A) and the production of the wild-type G2 subunit
(Fig. 2B).
pH-induced Conformational Changes in Furin-cleaved
rGPCfur
We reasoned that cleaved rGPCfur should differ from the
uncleaved protein in its response to acidic pH. Fusion activation in
class I fusion proteins typically results in the dissociation of
noncovalently associated receptor-binding and transmembrane
subunits [41]. Indeed, mammalian cells expressing GPC have
been shown to shed G1 on exposure to acidic pH [26]. We
therefore examined G1 shedding from cleaved rGPCfur as an
indication of pH-induced fusion activation. In these experiments,
lipid-reconstituted rGPCfur was incubated on the biosensor chip
with a bolus of sFurin (Fig. 4, middle trace, left). On washing, the
SPR response units (RUs) returned to the pre-digestion baseline,
indicating that no protein had been lost from the chip. Following
transient exposure to pH 5.0, however, the baseline signal was
reduced by ,800 RUs, consistent with pH-induced shedding of
G1 (Fig. 4, middle trace, center). By contrast, identical treatment
of the rGPCCD precursor resulted in no loss of protein (Fig. 4, top
trace). Based on the magnitude of the pH-induced loss from furin-
treated rGPCfur, we estimate that cleavage was ,70% complete
under these conditions. Susceptibility of rGPCfur to furin cleavage
may be enhanced by membrane anchorage.
To confirm that the pH-induced reduction in baseline RUs
reflects a loss of G1, we probed the same chip surface with a G1-
specific MAb [28]. Binding of MAb BF11 to cleaved rGPCfur was
markedly reduced after exposure to pH 5.0 relative to the
rGPCCD control (Fig. 4, right), indicative of pH-induced G1
shedding. Furthermore, the loss of G1 from cleaved rGPCfur was
found to be inhibited by ST-294 (Fig. 4, lower trace), in agreement
with results obtained using native GPC on the surface of
Figure 1. The GPCfur mutant is fusogenic in mammalian cell
culture. The furin cleavage-site mutation was introduced into the wild-
type G1G2 precursor, which was expressed in trans with SSP in Vero
cells. pH-induced cell-cell fusion activity relative to the wild-type GPC
was determined using a vaccinia virus-based beta-galactosidase fusion-
reporter assay as previously described [19]. Error bars indicate the
standard error of the mean. Background signals obtained in the
absence of SSP are #2% of wild-type.
doi:10.1371/journal.pone.0051114.g001
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mammalian cells [26]. We conclude rGPCfur can be functionally
matured in vitro and that the prefusion trimer is able to respond to
acidic pH in a manner consistent with on-path conformational
changes seen in the native GPC complex.
Proteolytic cleavage of the rGPCfur precursor was found to have
only a minimal effect on the extent and overall affinity of ST-294
binding (Kd = 2 mM vs. 4 mM) (Fig. 5A). However, exposure to
acidic pH markedly reduced the extent of subsequent ST-294
binding (Fig. 5A). The Kd of the residual binding was unaffected
and is likely attributable to uncleaved rGPCfur remaining on the
SPR chip. This notion is supported by observations that the
cleavage-defective rGPCCD can be repeatedly cycled at low pH
without loss of ST-294 binding activity (Fig. 5B). These latter
observations suggest that the trimeric precursor does not undergo
significant irreversible change in response to acidic pH. The
covalent linkage of the G1 and G2 subunits in the precursor likely
constrains pH-induced conformational excursions from the initial
state.
Furin-cleaved rGPCfur Mediates pH-dependent
Membrane Fusion
In order to determine whether cleaved rGPCfur is able to
mediate membrane fusion, we incorporated the recombinant
protein into LUVs and examined the ability of the proteolipo-
somes to fuse with target LUVs in a pH-dependent manner. The
target liposomes were doped with a self-quenching concentration
of rhodamine-PE, and fusion with the proteoliposome results in
dilution of the rhodamine within the merged lipids and
dequenching of the fluorophore [42]. At neutral pH, the liposome
mixture was stable over the course of 15 min, regardless of
whether proteoliposomes had previously been incubated with
sFurin (Fig. 6). Proteoliposomes bearing uncleaved rGPCfur were
likewise stable when exposed to acidic pH. By contrast,
acidification of sFurin-cleaved rGPCfur resulted in a rapid increase
in fluorescence over a period of 3 min (Fig. 6). After 5 min,
rhodamine-PE fluorescence approached ,30% of the maximum
obtained on complete dequenching in nonionic detergent.
Importantly, pH-induced fusion was inhibited by the prior
addition of ST-294, but not by the LASV-specific compound
ST-161 (Fig. 6). Thus, reconstituted rGPCfur is proteolytically
primed and can be activated by acidic pH to mediate fusion.
Rhodamine dequenching upon pH-induced activation demon-
strates mixing of the liposomal lipids. At a minimum, this result
indicates that cleaved rGPCfur is capable of inducing hemifusion,
an intermediate state in fusion where only the outer leaflets of the
two membranes merge. Previous studies have shown that
engineered envelope proteins linked to the cell membrane only
via a lipid glycophosphatidylinositol (GPI) anchor, or in which the
transmembrane domain is truncated, arrest at this hemifusion
intermediate [43–46]. To determine whether rGPCfur proteolipo-
somes can proceed to complete fusion, with merger of both
membrane leaflets and opening of a fusion pore, we monitored
pH-induced mixing of liposome contents. In these studies, target
liposomes containing the Zn++-sensitive fluorophore FluoZin-1
were mixed with rGPCfur proteoliposomes containing 50 mM
Zn++. Complete fusion with content mixing results in an increase
in FluoZin-1 fluorescence. Without sFurin-cleavage, only baseline
fluorescence was detected over a 20 min period at acidic pH
(Fig. 7A). Similarly, furin-treated proteoliposomes were stable at
neutral pH. By contrast, acidification of the cleaved rGPCfur
proteoliposomes led to a rapid increase in fluorescence that was
preceded by a lag period of ,2 min (Fig. 7A). By 10 min, content
mixing was ,40% of the maximum. The lag period in content
Figure 2. Purification and proteolytic cleavage of rGPCfur. A. Affinity-purified rGPCfur was subjected to size-exclusion chromatography (SEC)
and the peak fraction was analyzed by SDS-PAGE. Molecular weight markers used in SEC and SDS-PAGE are shown (in kilodaltons) and G1G2
precursor, G1 and G2 subunits and SSP are indicated. B. rGPCfur precursor was incubated with sFurin (+sFurin) and examined by SDS-PAGE (top
panel). MALDI mass spectrometry was used to determine the molecular weights of the deglycosylated (degly) G1 and G2 subunits. The calculated
mass is based on the assumption that all potential glycosylation sites are used and subsequently deglycosylated.
doi:10.1371/journal.pone.0051114.g002
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mixing may indicate a kinetic barrier for resolution of the
hemifusion intermediate [47]. Our results indicate that recon-
stituted rGPCfur mediates complete membrane fusion with content
mixing. In addition, we found that rGPCfur-mediated fusion was
markedly inhibited by ST-294, but not by the LASV-specific
inhibitor ST-161 (Fig. 7A). Taken together, our studies demon-
Figure 3. SPR studies of interactions with lipid-reconstituted rGPCfur. The rGPCfur precursor was immobilized onto a Biacore L1 chip and
reconstituted in a lipid bilayer as described in Material and Methods. Two or three concentration-dependent data sets were analyzed and sensorgram
figures were generated using a five-point smoothing procedure and ORIGIN graphing software. Labels to the right are drawn to coincide with the
maximum RUs achieved by the respective ligand. A. Binding of G1-directed MAbs (BF11, BF09, BE08, and AG02; 0.5 mM), sTfR (1.5 mM), and
a nucleoprotein-directed MAb (aN; BG12). B. Binding of SIGA (ST-294, ST-375, ST-193, and ST-761; 150 mM) and TSRI (17C8; 100 mM) small-molecule
fusion inhibitors. ST-161 and TSRI 8C1 are specific to the OW LASV and do not inhibit the NW arenavirus JUNV.
doi:10.1371/journal.pone.0051114.g003
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strate that recombinant rGPCfur faithfully reproduces the pH-
induced membrane-fusion activity of native GPC.
Distinct Modes of Antibody-mediated Neutralization
Reconstitution of the membrane-fusion reaction provides
a platform to investigate the mechanisms of antibody-mediated
virus neutralization. For example, MAb F100G5 has been shown
to recognize the fusion peptide of JUNV G2 [16] and, as this
Figure 4. SPR analysis of pH-induced G1 shedding. rGPC was immobilized onto a Biacore L1 chip and reconstituted in a lipid bilayer as
described [27]. The figure includes a composite of SPR responses from single-chip experiments in which rGPCCD (top trace) or rGPCfur (bottom two
traces) were sequentially incubated with sFurin (red arrow), exposed to pH 5.0 (blue arrow), and probed with the G1-specific MAb BF11 (black arrow).
In the lower trace, 20 mM of ST-294 was present throughout the experiment. The relative baseline before exposure to pH 5.0 is shown as a gray line
and the absolute RU values on the y-axis are arbitrary.
doi:10.1371/journal.pone.0051114.g004
Figure 5. SPR studies of ST-294 binding to rGPCfur following cleavage and exposure to acidic pH. A. ST-294 (100 mM) was bound to
lipid-reconstituted rGPCfur on a Biacore L1 chip prior to (black) and after (blue) sFurin cleavage, and following exposure of the latter to acidic pH (red).
Bound ST-294 was allowed to dissociate from the complex between subsequent injections. B. In a similar study using immobilized cleavage-defective
rGPCCD, ST-294 was bound prior to (blue) and following one and two sequential exposures to acidic pH (red and green, respectively).
doi:10.1371/journal.pone.0051114.g005
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region is sequestered in prefusion GPC, does not bind virions and
is therefore unable to inhibit entry following endocytic uptake of
the particle. Liposomal fusion by rGPCfur proteoliposomes was,
however, inhibited when F100G5 was present in the low-pH
buffer (Fig. 7B). This result recapitulates previous observations
from cell-cell fusion assays [16]. By contrast, the molecular basis
for virus neutralization by the G1-directed MAb BF11 [28] is
unknown. Interestingly, MAb BF11 did not inhibit proteoliposo-
mal fusion (Fig. 7B). We conclude that this MAb may block TfR
binding or virion internalization. This in vitro model of membrane
fusion offers unprecedented access for biochemical studies of GPC
function and its inhibition.
Discussion
Owing to the inherently labile nature of the prefusion envelope
glycoprotein, solubilization of class I fusion proteins from the
membrane typically destabilizes the trimeric structure sufficiently
to cause disassembly and/or refolding to the stable postfusion state
[48–50]. Indeed, this intrinsic instability has greatly hindered
biochemical and biophysical studies on the viral fusion machinery,
and frustrated efforts to design and develop native envelope
glycoproteins as effective vaccine immunogens [51]. We hypoth-
esize that the unique stability of GPC results from interaction
among the nine transmembrane domains in the trimeric complex
(vs. three in conventional class I fusion proteins), enforced by
intersubunit zinc-finger structures. The fortuitous resilience of
GPC offers the possibility for investigating the molecular basis of
membrane fusion mediated by a membrane-anchored envelope
glycoprotein in vitro.
Our current mechanistic understanding of viral membrane
fusion was developed in part from now-classical studies of
influenza virus HA (reviewed in reference [52]). High-resolution
crystallographic structures of the soluble HA ectodomain in its
precursor [53], prefusion [54] and postfusion [55] states serve as
reference points for the current model [53,56]. Recent studies of
PIV5 F [49,50] have reinforced central tenets of the model. These
crystallographic structures, as well as those of the stable postfusion
core of other class I fusion proteins, have all been determined
using soluble forms of the glycoprotein ectodomain and are
therefore silent with respect to the transmembrane and cytoplas-
mic domains. To our knowledge, this report is the first to
demonstrate full reconstitution of membrane-fusion activity by
a complete virus envelope glycoprotein.
Membrane anchorage is essential for membrane-fusion activity.
Envelope glycoprotein ectodomains anchored in the membrane by
a GPI lipid or truncated transmembrane domains are unable to
drive fusion to completion, arresting at the hemifusion state [43–
Figure 6. pH-induced membrane fusion by rGPCfur proteolipo-
somes: lipid mixing. rGPCfur was incorporated into POPG-POPC
liposomes and mixed with target POPG-POPC liposomes doped with
1% Rhodamine-PE. In most cases, the rGPCfur proteoliposomes were
first treated with sFurin (as indicated by+in the first position of the
labels, at right). Exposure to acidic pH at the start of the experiment
(time= 0) is indicated by+in the second position of the labels. 15 mM of
ST-294 or ST-161 was present prior to and during exposure to acidic pH,
where indicated. Lipid mixing and the resulting dequenching of the
rhodamine fluorophore were measured at 600 nm (excitation 508 nm).
Complete dequenching (100%) was determined by subsequent
solubilization in Triton X-100 nonionic detergent.
doi:10.1371/journal.pone.0051114.g006
Figure 7. pH-induced membrane fusion by rGPCfur proteoliposomes: content mixing. A. rGPCfur was incorporated into POPG-POPC-CHS
liposomes containing 50 mM Zn++ and these proteoliposomes were mixed with target POPG-POPC-CHS liposomes containing 1 mM FluoZin-1. The
experimental treatments, labels and colors are as described in the legend of Fig. 6. Content mixing was determined by Zn++-induced FluoZin-1
fluorescence measured at 485 nm (excitation 370 nm). Complete mixing was determined by solubilization with Triton X-100 in buffer containing
50 mM Zn++. B. pH-induced content mixing was determined in the continued presence of MAbs F100G5, BF11 or an irrelevant IgG (5 mM, 25 mM and
25 mM, respectively). In this experiment, content mixing in the absence of MAb (pH 5.0) was ,50%.
doi:10.1371/journal.pone.0051114.g007
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46]. Anchorage may be required to transduce forces generated
upon protein refolding towards complete fusion of the two
bilayers. Lateral contacts within the membrane between several
envelope glycoprotein spikes may also be important for formation
of the stable fusion pore. Membrane interactions of the
membrane-proximal ectodomain of HIV-1 Env are involved in
the fusion process and contribute to important determinants for
broadly neutralizing antibodies [57,58]. Furthermore, envelope
glycoprotein membrane-spanning domains also serve as conduits
to transmit information between the internal and external domains
for virion assembly and virus entry [59,60]. In GPC, amino-acid
changes in the membrane-proximal and transmembrane domains
have been shown to affect GPC biosynthesis and intracellular
trafficking of the complex [20,35], its sensitivity to acidic pH and
small-molecule fusion inhibitors [26,61,62] and, indeed, viral
pathogenesis [63,64]. Further analysis of GPC structure and
function using this biochemically defined in vitro system will
advance our understanding of the conformational transitions that
promote viral membrane fusion. This knowledge will directly
facilitate efforts to design novel entry inhibitors for the treatment
of arenavirus hemorrhagic fevers.
Acknowledgments
We are grateful to Alex Strongin (Sanford-Burnham Medical Research
Institute) and Martin Scott (Glaxo-SmithKline) for providing molecular
clones and advice for expression of soluble furin. We are also grateful to
Sean Amberg and Dongcheng Dai (SIGA Technologies) and Stefan Kunz,
Andrew Lee and Michael Oldstone (The Scripps Research Institute) for
providing small-molecule fusion inhibitors, and to Brian Crammer
(Colorado State University) for assistance in biosensor studies. SPR studies
were performed at the Proteomics Core of the Rocky Mountain Center of
Excellence for Biodefense and Emerging Infectious Diseases Research at
Colorado State University. We also thank the Baculovirus Expression Core
of the CoBRE Center for Biomolecular Structure and Dynamics at The
University of Montana for assistance with insect cell culture. G1-directed
JUNV MAbs were obtained from the CDC through the NIAID Biodefense
and Emerging Infectious Diseases Research Resources Repository.
Author Contributions
Conceived and designed the experiments: CJT SRS JHN. Performed the
experiments: CJT SS HEC JY. Analyzed the data: CJT SRS JHN. Wrote
the paper: CJT SRS JHN.
References
1. Harrison SC (2008) Viral membrane fusion. Nat Struct Mol Biol 15: 690–698.
2. White JM, Delos SE, Brecher M, Schornberg K (2008) Structures and
mechanisms of viral membrane fusion proteins: multiple variations on a common
theme. Crit Rev Biochem Mol Biol 43: 189–219.
3. Burton DR, Desrosiers RC, Doms RW, Koff WC, Kwong PD, et al. (2004) HIV
vaccine design and the neutralizing antibody problem. Nat Immunol 5: 233–
236.
4. McCormick JB, Webb PA, Krebs JW, Johnson KM, Smith ES (1987) A
prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis
155: 437–444.
5. Peters CJ (2002) Human infection with arenaviruses in the Americas. Curr Top
Microbiol Immunol 262: 65–74.
6. Delgado S, Erickson BR, Agudo R, Blair PJ, Vallejo E, et al. (2008) Chapare
virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case
in Bolivia. PLoS Pathog 4: e1000047.
7. Health and Human Services (2007) Implementation Plan for Chemical,
Biological, Radiological and Nuclear Threats.
8. NIAID (2009) NIAID Category A, B, and C Priority Pathogens.
9. Lenz O, ter Meulen J, Klenk H-D, Seidah NG, Garten W (2001) The Lassa
virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-
1/S1P. Proc Natl Acad Sci U S A 98: 12701–12705.
10. Beyer WR, Popplau D, Garten W, von Laer D, Lenz O (2003) Endoproteolytic
processing of the lymphocytic choriomeningitis virus glycoprotein by the
subtilase SKI-1/S1P. J Virol 77: 2866–2872.
11. Kunz S, Edelmann KH, de la Torre J-C, Gorney R, Oldstone MBA (2003)
Mechanisms for lymphocytic choriomeningitis virus glycoprotein cleavage,
transport, and incorporation into virions. Virology 314: 168–178.
12. Radoshitzky SR, Abraham J, Spiropoulou CF, Kuhn JH, Nguyen D, et al.
(2007) Transferrin receptor 1 is a cellular receptor for New World haemorrhagic
fever arenaviruses. Nature 446: 92–96.
13. Cao W, Henry MD, Borrow P, Yamada H, Elder JH, et al. (1998) Identification
of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and
Lassa fever virus. Science 282: 2079–2081.
14. Di Simone C, Zandonatti MA, Buchmeier MJ (1994) Acidic pH triggers LCMV
membrane fusion activity and conformational change in the glycoprotein spike.
Virology 198: 455–465.
15. Eschli B, Quirin K, Wepf A, Weber J, Zinkernagel R, et al. (2006) Identification
of an N-terminal trimeric coiled-coil core within arenavirus glycoprotein 2
permits assignment to class I viral fusion proteins. J Virol 80: 5897–5907.
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